“Interim recommendations for use of the AZD1222 (ChAdOx1-S [recombinant]) vaccine against COVID-19 developed by Oxford University and AstraZeneca”


WASHINGTON, D.C. (February 10, 2021)---the World Health Organization released "this interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) onImmunization at its extraordinary meeting on 8 February 2021 (1).Declarations of interests were collected from all external contributors and assessed…